News on the latest discoveries and experiments for the treatment and diagnosis of Cardiomyopathies.

Recommendations for patients: attention to the control of the subcutaneous defibrillators Emblem A209-A219

The utmost attention should be paid to checking the operation of the Emblem A209-A219 subcutaneous defibrillators as the device may need to be replaced due to premature and accelerated battery depletion.

February 02 2022|

Ritmodan, the President of Aicarm writes to AIFA

The antiarrhythmic drug Ritmodan and Ritmodan Retard are still unavailable in Italian pharmacies. Aifa has again postponed the deadline for the shortage and, as regards the Ritmodan Retard, it seems that we will have to wait until at least mid-February 2022.

December 14 2021|Tag: , |

Lisa Salberg: Shared decision making: the patient's perspective. A global vision

What does “shared decision-making” mean. Lisa Salberg founder and CEO of the American Association for Hypertrophic Myocarditis (HCMA) sent a video message to the "Advances in Cardiomyopathies" conference on 9-10 September, explaining how the concept is implemented in the United States. “We want patients to be excited about the future and understand their options and know how to ask smart questions that will help them achieve their goals,” he said. We publish broad passages from the speech that provide important elements for the discussion on the subject in Italy

October 14, 2021|

New study on the effectiveness of Covid-19 vaccines

We are told by prof. Bruno Cacopardo the work of an excellent group of Singapore researchers comparing the clinical and virological effects of the infection between vaccinated and unvaccinated. In this study it appears that, in addition to the well-known clinical protection (none of the vaccinated die and nobody goes to hospital), in the vaccinated the time of decline of the viral load (even if starting from the same concentration [...]

August 06 2021|

New drugs for Hypertrophic Cardiomyopathy

New drugs for Hypertrophic Cardiomyopathy

When one thinks of a heart disease, one generally thinks of a heart with a depressed function, as in the case of a patient with a previous extensive myocardial infarction, or of the classic classic decompensation called "hypokinetic" or with "reduced systolic function"
January 28 2021|
Back to the top